Atlas Trials

Marengo Therapeutics, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Marengo Therapeutics, Inc.

RecordFirmDate
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors (NCT06827613)Marengo Therapeutics, Inc.2025-03-24
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (NCT05592626)Marengo Therapeutics, Inc.2023-01-04

Track Marengo Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.